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The University of Mississippi 
Interoffice Memorandum 
SCHOOL OF PHARMACY 
OFFICE OF THE DEAN 
University, MS 38677 
Phone: (662) 915-7828  FAX: (662) 915-5704 
 
TO:  All School of Pharmacy and USDA Personnel 
 
FROM:  Charles D. Hufford, Associate Dean for Research and Graduate Programs  
 
DATE: August 24, 2012  
 
SUBJECT: Research News 
 
 
The following GRANTS/CONTRACTS have recently been awarded: 
1. Dr. Allison Bell (P.I.-Pharmacy Practice) and Dr. Kim Adcock (Co-P.I.-Pharmacy 
Practice). Instructional Innovation Award: Increasing Interprofessional Interactions Among 
UMMC Students (University of Mississippi Medical Center), $9,800, June 15, 2012-June 14, 
2013. 
2. Dr. Sandra Bentley (P.I.-Pharmacy Practice). Operation Immunization (The University of 
Southern Mississippi/Corporation for National and Community Service), $2,250, September 
1, 2011-August 31, 2012. 
3. Dr. Alice Clark (P.I.-NCNPR), and Dr. Ameeta Agarwal  (Co-P.I.-NCNPR). New Drugs 
for Opportunistic Infections-FY 12-13 (National Institute of Allergy and Infectious 
Diseases), $392,035, July 1, 2012-June 30, 2013. 
4. Dr. Ashley Ellis (P.I.-Pharmacy Practice). NACDS Foundation Faculty Scholars Program 
(National Association of Chain Drug Stores Foundation), $1,000, August 1, 2012-July 31, 
2013. 
5. Dr. Mahmoud ElSohly (P.I.-NCNPR), and Dr. Ikhlas Khan (Co-P.I.-NCNPR). Production, 
Analysis and Distribution of Cannabis, Marijuana Cigarettes and Related Materials-2011 
DEA Option-Modification No. 04 (National Institute on Drug Abuse), $42,000, August 8, 
2011-August 7, 2012. 
6. Dr. Mahmoud ElSohly (P.I.-NCNPR), and Dr. Ikhlas Khan (Co-P.I.-NCNPR). Production, 
Analysis and Distribution of Cannabis, Marijuana Cigarettes and Related Materials-Modification 
No. 05 (National Institute on Drug Abuse), $846,882, March 16, 2012-March 15, 2013. 
7. Dr. Mahmoud ElSohly (P.I.-NCNPR), and Dr. Ikhlas Khan (Co-P.I.-NCNPR). Production, 
Analysis and Distribution of Cannabis, Marijuana Cigarettes and Related Materials-2012 
DEA Option-Modification No. 07 (National Institute on Drug Abuse), $19,860, August 8, 
2012-August 7, 2013. 
8. Dr. Daneel Ferreira (P.I.-Pharmacognosy). Human Urinary Metabolites Produced as a 
Result of Cranberry Juice (Ocean Spray Cranberries, Inc.), $60,000, October 1, 2011-
September 30, 2012. 
9. Dr. Deborah Gochfeld (P.I.-NCNPR). EAGER: Developing a Model for Transmission of an 
Infectious Disease of Marine Sponges (National Science Foundation), $299,997, April 1, 
2012-March 31, 2014. 
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10. Dr. Melissa Jacob (P.I.-NCNPR). Development of New Agents Against Cryptococcal 
Infections FY 2011-12 (Florida Agricultural and Mechanical University/National Institutes 
of Health), $13,660, June 1, 2011-May 31, 2012. 
11. Dr. Seongbong Jo (P.I.-Pharmaceutics), and Dr. Robert Doerksen (Co-PI-Medicinal 
Chemistry). Computational Modeling-Aided Design, Synthesis and Evaluation of Redox-
Sensitive Polymer Nanoparticles for Cancer Targeted Drug Delivery (Mississippi State 
University/National Science Foundation/Experimental Program to Stimulate Competitive 
Research), $54,505, September 1, 2011-August 31, 2012. 
12. Dr. Ikhlas Khan (P.I.- NCNPR) and Dr. Troy Smillie (Co-P.I.-NCNPR). Botanical 
Estrogens: Mechanisms, Dose and Target Tissues-Amendment 1 (University of 
Illinois/National Institutes of Health), $197,740, September 1, 2011-August 31, 2012. 
13. Dr. Ikhlas Khan (P.I.-NCNPR), and Dr. Larry Walker (Co-P.I.-NCNPR). Discovery and 
Development of Natural Product-Based Insect Management Compounds for Medical, 
Veterinary and Urban Concern (United States Department of Agriculture/Agricultural 
Research Service), $450,850, July 1, 2011-June 30, 2012. 
14. Dr. Ikhlas Khan (P.I.-NCNPR), and Dr. Larry Walker (Co-P.I.-NCNPR). Discovery and 
Development of Natural Product-Based Insect Management Compounds for Medical, 
Veterinary and Urban Concern-Amendment 1 (United States Department of 
Agriculture/Agricultural Research Service), $315,288, July 1, 2011-June 30, 2012. 
15. Dr. Ikhlas Khan (P.I.- NCNPR) and Dr. Larry Walker (Co-P.I.-NCNPR). Science Based 
Authentication of Dietary Supplements FY11-12 (Food and Drug Administration), 
$2,093,000, September 15, 2011-August 31, 2012. 
16. Dr. Ikhlas Khan (P.I.- NCNPR) and Dr. Larry Walker (Co-P.I.-NCNPR). Science Based 
Authentication of Dietary Supplements FY12-13 (Food and Drug Administration), 
$2,308,000, September 1, 2012-August 31, 2013. 
17. Dr. Rahul Khanna (P.I.-Pharmacy Administration). Relationship Between Health Utility 
and Burden Among Caregivers of Autistic Children (American Association of Colleges of 
Pharmacy), $9,100, January 17, 2012-January 16, 2013. 
18. Dr. Xing-Cong Li (P.I.- NCNPR) and Dr. Melissa Jacob (Co-P.I.-NCNPR). Random Shear 
Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metagenomes (SBIR Phase II) 
- Year 1 (Lucigen Corporation/National Institutes of Health), $200,000, March 1, 2012-
February 28, 2013. 
19. Dr. Christopher McCurdy (P.I.-Medicinal Chemistry). Novel Pharmacologic Interventions 
for Drugs of Abuse-Year 5 (National Institutes of Health/National Institute on Drug Abuse), 
$24,192, April 1, 2011-March 31, 2012. 
20. Dr. Christopher McCurdy (P.I.-Medicinal Chemistry). Selective Sigma Receptor Ligands 
for Depression (The University of Mississippi Medical Center/National Institutes of 
Health/National Center for Research Resources), $7,207, July 1, 2011-June 30, 2012. 
21. Dr. S. Narasimha Murthy (P.I.-Pharmaceutics). A Novel Method to Treat Chronic Pain 
(National Institutes of Health/National Institute of Neurological Disorders and Stroke), 
$168,236, February 1, 2012-January 31, 2013. 
22. Dr. Dale Nagle (P.I.-Pharmacognosy), and Dr. Yu-Dong Zhou (Co-P.I.-Pharmacognosy). 
Anticancer Drug Discovery that Targets Tumor Hypoxia-Year 7 Revised (National Institutes 
of Health), $18,916, June 1, 2011-May 31, 2012. 
23. Dr. Dale Nagle (P.I.-Pharmacognosy), and Dr. Yu-Dong Zhou (Co-P.I.-Pharmacognosy). 
Anticancer Drug Discovery that Targets Tumor Hypoxia-Year 8 (National Institutes of 
Health), $262,130, June 1, 2012-May 31, 2013. 
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24. Dr. David Pasco (P.I.- NCNPR), Dr. Colin Jackson (Co-P.I.-Biology), Dr. Nirmal Pugh (Co-
P.I.-NCNPR), and Dr. Rita Moraes (Co-P.I.-NCNPR). Immune Enhancing Echinacea 
Bacterial Endophytes (National Institutes of Health), $365,132, April 1, 2012-March 31, 2013. 
25. Dr. Michael Repka (P.I.-Pharmaceutics) and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics). Properties of HME Extruded Films Containing Kollidon VA-64 and New 
Polymer, Soluplus - Year 3 (BASF SE), $38,679, January 1, 2011-December 31, 2012. 
26. Dr. Michael Repka (P.I.-Pharmaceutics) and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics). Pii Center for Pharmaceutical Technology (University of Mississippi 
Research Foundation), $50,000, May 1, 2012-April 30, 2013. 
27. Dr. Michael Repka (P.I.-Pharmaceutics) and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics). Fundamentals Studies in the Application of Ashland Aqualon Polymers for 
Hot-Melt Extrusion for the Oral Delivery of Soluble and Insoluble Drugs from Tablets, 
Capsules and Oral Film Dosage Forms-Year 1 (Hercules Inc.), $80,000, July 1, 2012-March 
31, 2013.    
28. Dr. John Rimoldi (P.I.-Medicinal Chemistry). Synthesis of Carbon Monoxide Donors and 
Heme Oxygenase Inhibitors-Amendment 4 (University of Mississippi Medical 
Center/National Institutes of Health/National Heart, Lung and Blood Institute), $27,096, 
September 1, 2011-July 31, 2012. 
29. Dr. John Rimoldi (P.I.-Medicinal Chemistry). Synthesis of Carbon Monoxide Donors and 
Heme Oxygenase Inhibitors-Amendment 5 (University of Mississippi Medical 
Center/National Institutes of Health/National Heart, Lung and Blood Institute), $28,421, 
September 1, 2012-May 31, 2013. 
30. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). University of Mississippi, School of 
Pharmacy and Baptist Memorial Hospital/North Mississippi Agreement FY11-12 (Baptist 
Memorial Hospital/North Mississippi), $73,530, August 3, 2011-August 3, 2012. 
31. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice), Dr. Lauren Bloodworth (Co-P.I.-Pharmacy 
Practice), and Dr. Courtney Davis (Co-P.I.-Pharmacy Practice). Project IMPACT: Diabetes 
(American Pharmacists Association Foundation), $25,000, August 31, 2011-December 31, 2013. 
32. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice), and Dr. Lauren Bloodworth (Co-P.I.-
Pharmacy Practice). Pharmacy Cardiovascular Risk Reduction Project - Year 2, (Mississippi 
State Department of Health/Centers for Disease Control and Prevention), $300,000, 
September 30, 2011-September 29, 2012.   
33. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). Community Pharmacy Residency Practice 
Site Agreement (Walgreens Co.), $12,500, January 23, 2012-January 22, 2013. 
34. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). Together on Diabetes in the Mississippi Delta 
Region #2 (Mississippi Public Health Institute), $3,450, May 21, 2012-July 31, 2012. 
35. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). Clinical Services Support (University of 
Mississippi Medical Center), $6,000, January 1, 2012-December 31, 2012. 
36. Dr. Ziaeddin Shariat-Madar (P.I.-Pharmacology). Development of a Clinical 
Prolylcarboxypeptidase Assay (U.S. Small Business Administration), $41,951, January 1, 
2012-July 1, 2012. 
37. Dr. Justin Sherman (P.I.-Pharmacy Practice). A “Train-the-Trainers” Initiative to Implement 
Smoking Cessation Programs (The University of Southern Mississippi/Corporation for National 
and Community Service), $5,000, September 1, 2011-August 31, 2012. 
38. Dr. Gregory Tschumper (P.I.-Chemistry), Dr. Amal Dass, Dr. Nathan Hammer, Dr. Keith 
Hollis, Dr. Randy Wadkins (Co-P.I’s-Chemistry and Biochemistry); Dr. Yixin Chen (Co-
P.I.-Computer and Information Science); Dr. Robert Doerksen (Co-P.I.-Medicinal 
Chemistry); and Dr. Maxine Harper  (Co-P.I.-Center for Educational Research and 
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Evaluation). Modeling and Simulation of Complex Systems (Mississippi State 
University/National Science Foundation), $735,689, September 1, 2011-August 31, 2012. 
39. Dr. Larry Walker (P.I.-NCNPR). Discovery and Development of Natural Products for 
Pharmaceutical and Agrichemical Applications-Amendment No. 1 (United States 
Department of Agriculture/Agricultural Research Service), $2,619,477, June 1, 2011-May 
30, 2012. 
40. Dr. Larry Walker (P.I.-NCNPR). Discovery and Development of Natural Products for 
Pharmaceutical and Agrichemical Applications-Amendment No. 2 (United States 
Department of Agriculture/Agricultural Research Service), $1,506,749, June 1, 2011-May 
30, 2012. 
41. Dr. Larry Walker (P.I.-NCNPR). OBCR Bioassay Support (NOAA/NIUST), $37,195, 
2012-2013. 
42. Dr. Donna West-Strum (P.I.-Pharmacy Administration), Dr. David McCaffrey (Co-P.I.-
Pharmacy Administration), Dr. Erin Holmes (Co-P.I.-Pharmacy Administration), Dr. John 
Bentley (Co-P.I.-Pharmacy Administration), and Dr. Patrick Pace (Co-P.I.-Pharmacy 
Administration). Measuring and Improving Primary Medication Non-adherence (National 
Association of Chain Drug Stores Foundation), $278,958, July 19, 2011-July 31, 2013. 
43. Dr. Kristine Willett (P.I.-Pharmacology & Environmental Toxicology Research Program). 
Development of a Fish Model for Epigenetic and Multigenerational Contaminant Effect 
(National Institutes of Health/National Institute of Environmental Health Sciences), 
$205,900, August 12, 2011-July 31, 2012. 
44. Dr. Kristine Willett (P.I.-Pharmacology & Environmental Toxicology Research Program). 
Development of a Fish Model for Epigenetic and Multigenerational Contaminant Effect-Year 
2 (National Institutes of Health/National Institute of Environmental Health Sciences), 
$178,750, August 1, 2012-July 31, 2013. 
45. Dr. Kristine Willett (P.I.-Pharmacology). Distribution, Bioaccumulation and Toxicity of 
Nanosilver Particles in Medaka (Oryzias latipes)-Year 3 (U.S. Army Engineering Research 
and Development Center), $248,000, February 27, 2012-February 26, 2013. 
46. Dr. Yi Yang (P.I.-Pharmacy Administration). Assessment of Communications-Related 
Needs for Decision Makers (International Society for Pharmacoeconomics and Outcomes 
Research), $7,237, June 1, 2012-August 31, 2012. 
47. Dr. Jordan Zjawiony (P.I.-Pharmacognosy). Diterpenes as Selective Kappa Opioid 
Receptor Agents (The University of North Carolina at Chapel Hill/National Institute on Drug 
Abuse), $70,523, February 15, 2012-January 31, 2013. 
48. Dr. Jordan Zjawiony (P.I.-Pharmacognosy). Psychopharmacology of Plants and Their 
Metabolites Used as Marijuana Substitutes-Year 2 (National Institutes of Health), $71,500, 
June 1, 2012-May 31, 2013. 
 
 
The following PUBLICATIONS have appeared: 
1. Gabriella Avielo, Francesca Borrelli, Francesca Guida, Barbara Romano, Kevin Lewellyn, 
Maria De Chiaro, Livio Luongo, Jordan K. Zjawiony, Sabatino Maione, Angelo A. Izzo, and 
Raffaele Capasso. “Ultrapotent effects of salvinorin A, a hallucinogenic compound from 
Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action 
In Vivo”, J Mol Med, 89 (2011) 891-902.  
2. Bharathi Avula, Yan-Hong Wang, Chidananda Swamy Rumalla, Zulfiqar Ali, Troy J. 
Smillie, and Ikhlas A. Khan. “Analytical methods for determination of magnoflorine and 
saponins from roots of Caulophyllum thalictroides (L.) Michx. Using UPLC, HPLC and 
HPTLC”, Journal of Pharmaceutical and Biomedical Analysis, 56 (2011) 895-903. 
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3. Bharathi Avula, Yan-Hong Wang, Rita M. Moraes, and Ikhlas A. Khan. “Rapid analysis of 
lignans from leaves of Podophyllum peltatum L. samples using UPLC-UV-MS”, Biomed. 
Chromatogr, 25 (2011) 1230-1236. 
4. Sridhar Rao Ayinampudi, Yan-Hong Wang, Bharathi Avula, Troy J. Smillie, and Ikhlas A. 
Khan. “Quantitative Analysis of Oxyresveratrol in Different Plant Parts of Morus Species 
and Related Genera by HPTLC and HPLC”, Journal of Planar Chromatography, 24 (2011) 
125-129. 
5. Joanna Bajsa, Zhiqiang Pan, and Stephen O. Duke. “Transcriptional responses to cantharidin, 
a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple 
signal transduction pathways”, Physiologia Plantarum, 143 (2011) 188-205. 
6. John Bentley. “Marketing Theory”, Pharmacy Management, Third Edition, Edited by Shane 
P. Desselle, David P. Zgarrick, and Gregory L. Alston, (2012) 377-403. 
7. Abhijeet Bhanegaonkar, Suresh Madhavan, Rahul Khanna, and Scot C. Remick. “Declining 
Mammography Screening in a State Medicaid Fee-for-Service Program: 1999-2008”, 
Journal of Women’s Health, DOI: 10.1089/jwh.2011.2748 (2012). 
8. Robert V. Brown, Forest L. Danford, Vijay Gokhale, Laurence H. Hurley, and Tracy A. 
Brooks. “Demonstration That Drug-Targeted Downregulation of MYC in Non-Hodgkins 
Lymphoma is Directly Mediated Through the Promoter G-Quadruplex”, The American 
Society for Biochemistry and Molecular Biology, DOI: 10.1074/jbc.M111.274720 (2011). 
9. Walter G. Chambliss, Wesley A. Carroll, Daniel Kennedy, Donald Levine, Michael A. 
Moné, L. Douglas Ried, Marv Shepherd, and Mukund Yelvigi. “Role of the pharmacist in 
preventing distribution of counterfeit medications”, Journal of the American Pharmacists 
Association, 52 (2012) 195-199. 
10. Suman Chandra, Hemant Lata, Ikhlas A. Khan, and Mahmoud A. ElSohly. “Photosynthetic 
response of Cannabis sativa L., an important medicinal plant, to elevated levels of CO2”, 
Physiology and Molecular Biology of Plants, 17 (2011) 291-295. 
11. Suman Chandra, Hemant Lata, Ikhlas A. Khan, and Mahmoud A. ElSohly. “Temperature 
response of photosynthesis in different drug and fiber varieties of Cannabis sativa L.”, 
Physiology and Molecular Biology of Plants, 17 (2011) 297-303. 
12. John D. Cleary and Kishor M. Wasan. “Amphotericin B: A New Look at Cellular Binding”, 
The Open Antimicrobial Agents Journal, 3 (2011) 30-36. 
13. Brian L. Crabtree, Victor G. Dostrow, Cynthia J. Evans, Brian J. Cuffel, Jose Ma. J. Alvir, 
and Kafi N. Sanders. “Outcome Assessment of an Antipsychotic Drug Algorithm: Effects of 
the Mississippi State Hospital Algorithm Project”, Psychiatric Services, 62 (2011) 963-965. 
14. Franck E. Dayan, J’Lynn Howell, Jannie P. Marais, Daneel Ferreira, and Marja Koivunen. 
“Manuka Oil, A Natural Herbicide with Pre-emergence Activity”, Weed Science, 59 (2011) 
464-469. 
15. S. O. Duke and F. E. Dayan. “Bioactivity of Herbicides”, Comprehensive Biotechnology, 4 
(2011) 23-35. 
16. Daneel Ferreira and Christina M. Coleman. “Towards the Synthesis of Proanthocyanidins: 
Half a Century of Innovation”, Planta Med., 77 (2011) 1071-1085. 
17. J. Fichna, M. Dicay, S. A. Hirota, D. Traboulsi, J. A. MacDonald, A. Janecka, P. L. Beck, J. 
K. Zjawiony, W. K. MacNaughton, and M. A. Storr. “Differential effects of salvinorin A on 
endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum”, 
Neurogastroenterology & Motility, 23 (2011) 582-590.   
18. Jiangtao Gao, Francisco León, Mohamed M. Radwan, Olivia R. Dale, Afeef S. Husni, Susan 
P. Manly, Shari Lupien, Xiaoning Wang, Robert A. Hill, Frank M. Dugan, Horace G. Cutler, 
and Stephen J. Cutler. “Benzyl Derivatives with In Vitro Binding Affinity for Human Opioid 
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Receptors and Cannabinoid Receptors from the Fungus Eurotium repens” Journal of Natural 
Products, 74 (2011) 1636-1639. 
19. Jiangtao Gao and Mark T. Hamann. “Chemistry and Biology of Kahalalides”, Chemical 
Reviews, 111 (2011) 3208-3235. 
20. Adrienne M. Gilligan, Jaclyn Myers, James D. Nash, Jill E. Lavigne, Leticia R. 
Moczygemba, Kimberly S. Plake, Ana C. Quiñones-Boex, David Holdford, Donna West-
Strum, and Terri L. Warholak. “Educating Pharmacy Students to Improve Quality (EPIQ) in 
Colleges and Schools of Pharmacy”, American Journal of Pharmaceutical Education, 76 
(2012) Article 109. 
21. Yang-Qing He, Guo-Yi Ma, Jiang-nan Peng, Zhan-Ying Ma, and Mark T. Hamann. “Liver X 
receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia”, 
Biochimica et Biophysica Acta, (2012) 1021-1026. 
22. Tushar Hingorani, Waseem Gul, Mahmoud ElSohly, Michael A. Repka, and Soumyajit 
Majumdar. “Effect of Ion Pairing on In Vitro Transcorneal Permeability of a !9-
Tetrahydrocannabinol Prodrug: Potential in Glaucoma Therapy”, Journal of Pharmaceutical 
Sciences, DOI: 10.1002/jps.22791 (2011).  
23. Ketan Hippalgaonkar, Waseem Gul, Mahmoud A. ElSohly, Michael A. Repka, and 
Soumyajit Majumdar. “Enhanced Solubility, Stability, and Transcorneal Permeability of 
Delta-8-Tetrahydrocannabinol in the Presence of Cyclodextrins”, AAPS PharmSciTech, 12 
(2011) 723-731.  
24. Ketan Hippalgaonkar, Soumyajit Majumdar, and Viral Kansara. “Injectable Lipid 
Emulsions—Advancements, Opportunities and Challenges”, AAPS PharmSciTech, 11 (2011) 
1526-1540. 
25. Erin R. Holmes, and Shane P. Desselle. “The use of speech disfluency as an indicant of 
paradigm development in pharmacy’s academic subdisciplines”, Research in Social & 
Administrative Pharmacy, DOI: 10.1016/j.sapharm.2011.11.005 (2012). 
26. Erin R. Holmes and Leigh Ann Bynum, “Customer Service”, Pharmacy Management, Third 
Edition, Edited by Shane P. Desselle, David P. Zgarrick, and Gregory L. Alston, (2012) 219-
237. 
27. Krutika S. Jariwala, Erin R. Holmes, Benjamin F. Banahan, and David J. McCaffrey. 
“Adoption of and experience with e-prescribing by primary care physicians”, Research in 
Social & Administrative Pharmacy, DOI: 10.1016/j.sapharm.2012.04.003 (2012). 
28. Rahul Khanna, S. Suresh Madhavan, Michael J. Smith, Cindy Tworek, Julie H. Patrick, and 
Barbara Becker-Cottrill. “Psychometric properties of the Caregiver Strain Questionnaire 
(CGSQ) among caregivers of children with autism”, Autism, DOI: 
10.1177/1362361311406143 (2011).  
29. Rahul Khanna, and Krutika Jariwala. “Awareness and knowledge of autism among 
pharmacists”, Research in Social and Administrative Pharmacy, DOI: 
10.1016/j.sapharm.2011.11.002 (2011).  
30. Rahul Khanna, Patrick F. Pace, Rohan Mahabaleshwarkar, Ram Sankar Basak, Manasi 
Datar, and Benjamin F. Banahan. “Medication Adherence Among Recipients with Chronic 
Diseases Enrolled in a State Medicaid Program”, Population Health Management, DOI: 
10.1089/pop.2011.0069 (2012).  
31. R. Khanna, K. Jariwala, and D. West-Strum. “Use and cost of psychotropic drugs among 
recipients with autism in a state Medicaid fee-for-service programme”, DOI: 10.1111/j.1365-
2788.2012.01563.x (2012). 
32. Sean R. King, David J. McCaffrey, and Alicia S. Bouldin. “Health literacy in the pharmacy 
setting: defining pharmacotherapy literacy”, Pharmacy Practice (2011) 213-220. 
 7 
33. Anna J. Kochanowska-Karamyan and Mark T. Hamann. “Marine Indole Alkaloids: Potential 
New Drug Leads for the Control of Depression and Anxiety”, Chemical Reviews, 110 (2010) 
4489-4497.   
34. Hemant Lata, Suman Chandra, Natascha Techen, Ikhlas A. Khan, and Mahmoud A. ElSohly. 
Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic 
(encapsulated) seeds following in vitro storage conditions”, Biotechnology Letters, 33 (2011) 
2503-2508. 
35. Hemant Lata, Suman Chandra, Zlatko Mehmedic, Ikhlas A. Khan, and Mahmoud A. 
ElSohly. “In vitro germplasm conservation of high !9–tetrahydrocannabinol yielding elite 
clones of Cannabis sativa L. under slow growth conditions”, Acta Physiol Plant, DOI: 
10.1007/s11738-011-0874-x (2011).  
36. Taotao Ling, Jing Xu, Ryan Smith, Abbas Ali, Charles L. Cantrell, and Emmanuel A. 
Theodorakis. “Synthesis of (–)-callicarpenal, a potent arthropod repellent”, Tetrahedron, 67 
(2011) 3023-3029.  
37. Tasneem Lokhandwala, Donna West-Strum, Benjamin F. Banahan, John P. Bentley, and Yi 
Yang. “Do statins improve outcomes in patients with asthma on inhaled corticosteroid 
therapy? A retrospective cohort analysis”, BMJ Open, DOI:10.1136/bmjopen-2012-001279 
(2012). 
38. Zhenyu Lu, Yuanqing Ding, Xing-Cong Li, Daignon R. Djigbenou, Brian T. Grimberg, 
Daneel Ferreira, Chris M. Ireland, and Ryan M. Van Wagoner. “3-Bromohomofascaplysin A, 
a fascaplysin analogue from a Fijian Didemnum sp. ascidian”, Bioorganic & Medicinal 
Chemistry, 19 (2011) 6604-6607. 
39. Prashanth Manda, Jamie K. Hargett, Siva Ram Kiran Vaka, Michael A. Repka, and S. 
Narasimha Murthy. “Delivery of cefotaxime to the brain via intranasal administration”, Drug 
Development and Industrial Pharmacy, 37 (2011) 1306-1310. 
40. Zankhana Master, Amit Chaudhary, Thomas R. Sutter, and Kristine L. Willett. “Effects of 
flavonoids on CYP1 expression in RL95-2 endometrial carcinoma cells”, Food Chemistry, 
133 (2012) 912-922. 
41. Melissa Medina, Dana Hammer, Renee Rose, Steven Scott, Freddy M. Creekmore, Amy 
Pittenger, Robert Soltis, Alicia Bouldin, Lindsay Schwartz, and Peggy Piascik. 
“Demonstrating excellence in pharmacy teaching through scholarship”, Currents in 
Pharmacy Teaching and Learning, 3 (2011) 255-259. 
42. Rita M. Moraes, Hemant Lata, Joko Sumyanto, Ana M. S. Pereira, Bianca W. Bertoni, 
Vaishali C. Joshi, Nirmal D. Pugh, Ikhlas A. Khan, and David S. Pasco. “Characterization 
and pharmacological properties of in vitro propagated clones of Echinacea tennessensis 
(Beadle) Small”, Plant Cell Tiss Organ Cult, (2011) 309-315. 
43. Anroop B. Nair, Siva Ram Kiran Vaka, Sumit Gupta, Michael A. Repka, and S. Narasimha 
Murthy. “In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch 
system of alfuzosin hydrochloride”, Pharmaceutical Development and Technology, DOI: 
10.3109/10837450.2010.522585 (2010).  
44. Anroop B. Nair, Siva Ram Kiran Vaka, and S. Narasimha Murthy. “Transungual delivery of 
terbinafine by iontophoresis in onychomycotic nails”, Drug Development and Industrial 
Pharmacy, 37 (2011) 1253-1258. 
45. N. P. Dhammika Nanayakkara, and Kevin K. Schrader. “Evaluation of free radical-
generating compounds for toxicity towards the cyanobacterium Planktothrix perornata, 
which causes musty off-flavour in pond-raised channel catfish (Ictalurus punctatus)”, 
Aquaculture Research, 42 (2011) 1895-1898. 
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46. Tarannum Naz, Ashik Mosaddik, Motiur Rahman, Ilias Muhammad, Ekramul Haque, and 
Somi Kim Cho. “Antimicrobial, antileishmanial and cytotoxic compounds from Piper 
chaba”, Natural Product Research, DOI: 10.1080/14786419.2010.535166 (2011). 
47. Peggy Piascik, Alicia Bouldin, Lindsay Schwartz, Amy Pittenger, Melissa Medina, Renee 
Rose, Robert Soltis, Steven Scott, Freddy M. Creekmore, and Dana Hammer. “Rewarding 
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TECHNOLOGY TRANSFER transactions:  
(In the interest of protecting confidential information, the names and titles associated with 
School of Pharmacy invention disclosures and patent applications will no longer be published 
until after a patent has issued.) 
Research Disclosures Filed July 1, 2011 to June 30, 2012:   5 
U. S. Patent Applications Pending:   19 
Recent U. S. Patents Granted: 1 
UM 1971 Pterostilbene as a New Agonist for the Peroxisome Proliferator-Activated Alpha 
Isoform 
US Patent number 8,133,917, issued 3/13/2012 





The following SPECIAL ANNOUNCEMENTS are also listed: 
• Christina Coleman (Pharmacognosy) and Gang Fu (Medicinal Chemistry) were honored 
with Graduate Achievement Awards for 2012 during School of Pharmacy 
Commencement activities in May. 
 
 
Please continue to send me important research and graduate information so that I might share it 
with your faculty colleagues.   
 
cc: Ms. Euphiazene Gray, Office of Research 
